Join
Live feed
·
PRReleasevia Quantisnow
Telix Pharmaceuticals Limited logo

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

ByQuantisnow·Wall Street's wire, on your screen.
TLX· Telix Pharmaceuticals Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TLX (Telix Pharmaceuticals Limited) and more on Quantisnow.